Testing effectiveness (Phase 2)Study completedNCT01693783
What this trial is testing
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer
Who this might be right for
Cervical AdenocarcinomaCervical Squamous Cell CarcinomaHuman Papillomavirus Infection+3 more
National Cancer Institute (NCI) 42